398 results on '"Kellam, Barrie"'
Search Results
2. Characterizing the binding of glycoprotein VI with nanobody 35 reveals a novel monomeric structure of glycoprotein VI where the conformation of D1+D2 is independent of dimerization
3. A novel and selective fluorescent ligand for the study of adenosine A2B receptors.
4. Visualizing Ligand Binding to a GPCR In Vivo Using NanoBRET.
5. CXCL17 is an allosteric inhibitor of CXCR4 through a mechanism of action involving glycosaminoglycans
6. Ligand-Directed Labeling of the Adenosine A1 Receptor in Living Cells.
7. Monitoring Allosteric Interactions with CXCR4 Using NanoBiT Conjugated Nanobodies
8. NanoBiT Complementation to Monitor Agonist-Induced Adenosine A1 Receptor Internalization
9. Design, Synthesis, and Evaluation of New 1H-Benzo[d]imidazole Based PqsR Inhibitors as Adjuvant Therapy for Pseudomonas aeruginosa Infections
10. Small Molecule Fluorescent Ligands for the Atypical Chemokine Receptor 3 (ACKR3)
11. Subtle modifications to a thieno[2,3-d]pyrimidine scaffold yield negative allosteric modulators and agonists of the dopamine D2 receptor
12. A time-resolved Forster resonance energy transfer assay to investigate inhibitor binding to ABCG2
13. Visualizing Ligand Binding to a GPCR In Vivo Using NanoBRET
14. Ligand-directed covalent labelling of a GPCR with a fluorescent tag in live cells
15. Small Molecule Fluorescent Ligands for the Atypical Chemokine Receptor 3 (ACKR3).
16. Small-Molecule Fluorescent Ligands for the CXCR4 Chemokine Receptor
17. The development of novel solid phase methodologies for the synthesis of atypical peptides and non-peptide entities
18. Antitumour benzothiazoles. Part 32: DNA adducts and double strand breaks correlate with activity; synthesis of 5F203 hydrogels for local delivery
19. Characterizing the binding of GPVI with nanobody 35 reveals a novel monomeric structure of GPVI where the conformation of D1+D2 is independent of dimerization.
20. Science and Practice back together again
21. 5-Deazaflavin derivatives as inhibitors of p53 ubiquitination by HDM2
22. Passerini chemistries for synthesis of polymer pro-drug and polymersome drug delivery nanoparticles
23. Synthesis, characterisation and evaluation of hyperbranched N-(2-hydroxypropyl) methacrylamides for transport and delivery in pancreatic cell lines in vitro and in vivo
24. Optimization of Peptide Linker-Based Fluorescent Ligands for the Histamine H1 Receptor
25. Synthesis, characterisation and evaluation of hyperbranched N-(2-hydroxypropyl) methacrylamides for transport and delivery in pancreatic cell lines in vitro and in vivo
26. Design and Evaluation of New Quinazolin-4(3 H)-one Derived PqsR Antagonists as Quorum Sensing Quenchers in Pseudomonas aeruginosa
27. Identification of a novel toxicophore in anti-cancer chemotherapeutics that targets mitochondrial respiratory complex I
28. Subtype selective fluorescent ligands based on ICI 118,551 to study the human ?2?adrenoceptor in CRISPR/Cas9 genome?edited HEK293T cells at low expression levels
29. Design and Evaluation of New Quinazolin-4(3H)-one Derived PqsR Antagonists as Quorum Sensing Quenchers in Pseudomonas aeruginosa
30. Efficient G protein coupling is not required for agonist?mediated internalization and membrane reorganization of the adenosine A 3 receptor
31. Subtype selective fluorescent ligands based on ICI 118,551 to study the human β2‐adrenoceptor in CRISPR/Cas9 genome‐edited HEK293T cells at low expression levels
32. Design and Evaluation of New Quinazolin-4(3H)-one Derived PqsR Antagonists as Quorum Sensing Quenchers in Pseudomonas aeruginosa
33. Synthesis and matched molecular pair analysis of covalent reversible inhibitors of the cysteine protease CPB
34. Effect of a toggle switch mutation in TM6 of the human adenosine A3 receptor on Gi protein-dependent signalling and Gi-independent receptor internalization
35. Allosteric interactions at adenosine A1 and A3 receptors: new insights into the role of small molecules and receptor dimerization
36. The evolving small-molecule fluorescent-conjugate toolbox for Class A GPCRs
37. Optimization of Peptide Linker-Based Fluorescent Ligands for the Histamine H1 Receptor.
38. Development and Application of Subtype-Selective Fluorescent Antagonists for the Study of the Human Adenosine A1 Receptor in Living Cells
39. Efficient G protein coupling is not required for agonist‐mediated internalization and membrane reorganization of the adenosine A 3 receptor
40. Subtype-Selective Fluorescent Ligands as Pharmacological Research Tools for the Human Adenosine A2A Receptor
41. Overcoming challenges in developing small molecule inhibitors for GPVI and CLEC-2
42. Design and Use of Fluorescent Ligands to Study Ligand–Receptor Interactions in Single Living Cells
43. A novel lipoamino acid based system for delivery of Leu-enkephalinamide derivatives through the blood-brain barrier
44. Novel Dde-protected glycoamino acids and glycoazido acids in saccharopeptide synthesis
45. Using Esterase Selectivity to Determine the In Vivo Duration of Systemic Availability and Abolish Systemic Side Effects of Topical β-Blockers
46. Identification of a novel toxicophore in anti-cancer chemotherapeutics that targets mitochondrial respiratory complex I
47. Author response: Identification of a novel toxicophore in anti-cancer chemotherapeutics that targets mitochondrial respiratory complex I
48. Ligand-directed covalent labelling of a GPCR with a fluorescent tag
49. Monitoring ligand-induced changes in receptor conformation with NanoBiT conjugated nanobodies
50. Low intrinsic efficacy for G protein activation can explain the improved side effect profiles of new opioid agonists
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.